Illwane Pharmaceuticals Llp - Company Profile

It is a business services limited liability partnership based in Gandhinagar, Gujarat, India, established in 2019.
2019 Gandhinagar, Gujarat, India Active
Last Updated:
About Illwane Pharmaceuticals Llp

Illwane Pharmaceuticals Llp, a active limited liability partnership, was established on 10 May 2019 in Gandhinagar, Gujarat, India. Engaging in other services within the business services sector, it holds LLPIN: AAP-2568. Registered under ROC Roc Ahmedabad. It has total obligation of contribution of ₹0.10 M.

Its leadership includes Mamta Sharad Gangani (Designated Partner), Sharad Hemrajbhai Gangani (Designated Partner). Past directors included Yogeshkumar Bhikhabhai Patel. Its latest date of accounts and solvency statement 31 March 2025. It is based at Laxmipura, At & Post Arsodiya,Vill: Arsodiya, Taluka: Kalol, District: Gandhingar,, Gandhinagar, Gujarat, 382721.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    AAP-2568

  • Incorporation Date

    10 May 2019

  • Total Obligation of Contribution

    ₹0.10 M

  • ROC Code

    Roc Ahmedabad

  • Company Status

    Active

Key Metrics
  • Obligation of Contribution ₹ 0.10 M
  • Company Age 6 Year, 9 Months
  • Last Filing with ROC 31 Mar 2025
Company report

Illwane Pharmaceuticals Llp

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Illwane Pharmaceuticals Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Illwane Pharmaceuticals Llp?
Current Designated Partners
Name Designation Appointment Date Status
Mamta Sharad Gangani Designated Partner 18 Sep 2023 Current
Sharad Hemrajbhai Gangani Designated Partner 10 May 2019 Current
Past Designated Partners
Name Designation Cessation Status
Pramod Abcsdd Designated Partner 18 Sep 2023 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Illwane Pharmaceuticals Llp.

Enhance accessibility to Illwane Pharmaceuticals Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Illwane Pharmaceuticals Llp revenue growth over time
Illwane Pharmaceuticals Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Illwane Pharmaceuticals Llp?

Unlock access to Illwane Pharmaceuticals Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Illwane Pharmaceuticals Llp?

Unlock and access historical data on people associated with Illwane Pharmaceuticals Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Illwane Pharmaceuticals Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Illwane Pharmaceuticals Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Illwane Pharmaceuticals Llp
Recent Activity within the Organization
  • Annual General Meeting

    The activity Illwane Pharmaceuticals Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records. was completed.

  • Statement of Assets & Liabilities

    The activity Illwane Pharmaceuticals Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was completed.

  • Director Appointment

    Mamta Sharad Gangani was appointed as a Designated Partner was appointed as a Designated Partner on 18 Sep 2023 & has been associated with this company since 2 years 5 months . was recorded as a recent event.

  • Director Appointment

    The activity Sharad Hemrajbhai Gangani was appointed as a Designated Partner was appointed as a Designated Partner on 10 May 2019 & has been associated with this company since 6 years 9 months . was completed.

  • LLP Incorporation

    Illwane Pharmaceuticals Llp was registered on 10 May 2019 with Roc Ahmedabad & aged 6 years 9 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Illwane Pharmaceuticals Llp?

The LLPIN of Illwane Pharmaceuticals Llp is AAP-2568.

Where is Illwane Pharmaceuticals Llp headquartered?

Illwane Pharmaceuticals Llp is headquartered at Laxmipura, At & Post Arsodiya,Vill: Arsodiya, Taluka: Kalol, District: Gandhingar,, Gandhinagar, Gujarat, 382721.

When was Illwane Pharmaceuticals Llp incorporated?

Illwane Pharmaceuticals Llp was incorporated on 10 May 2019.

Who are the current directors of Illwane Pharmaceuticals Llp?

The current directors of Illwane Pharmaceuticals Llp are

What is the primary industry of Illwane Pharmaceuticals Llp?

The primary industry of Illwane Pharmaceuticals Llp is Business Services.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available